≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback
info icon

Adenocarcinoma and Papillary adenocarcinoma of kidney

Endpoint Browser

C3_KIDNEY_PAPILLARYADENO

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Cancer registry: Topography ICD-O-3 — C64
  • Cancer registry: Morphology ICD-O-3 — 8260
  • Cancer registry: Behaviour codes — 3

1 out of 7 registries used, show all original rules.

345

4. Check minimum number of events

None

345

5. Include endpoints

None

345

6. Filter based on genotype QC (FinnGen only)

345

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy
4
First used in FinnGen datafreeze
DF9

Similar endpoints

↥

List of similar endpoints to Adenocarcinoma and Papillary adenocarcinoma of kidney based on the number of shared cases.

Venn diagram with an highlighted set fully inside another set Similar with more cases:

Venn diagram with a set fully inside an highlighted set Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Not enough data for upset plot.

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 345 83 262
Unadjusted period prevalence (%) 0.09 0.03 0.12
Median age at first event (years) 67.04 67.58 66.87

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
322
Matched controls
3218
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
3045.4
323.0
311
29
8260/3-C64.9
ICD-O-3
Papillary adenocarcinoma, NOS, of kidney, NOS
+∞
323.0
322
*
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
415.9
299.5
267
37
KAD00
NOMESCO Finland
Partial nephrectomy
188.4
83.6
84
6
KAD01
NOMESCO Finland
Percutaneous endoscopic partial nephrectomy
302.2
72.5
71
*
B01AB10
ATC
tinzaparin; parenteral
13.8
58.9
109
115
KAC10
NOMESCO Finland
Total nephrectomy with capsule
97.3
58.4
63
8
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
39.6
50.9
64
20
KAC11
NOMESCO Finland
Total nephrectomy with capsule, transcutaneous
82.5
49.9
55
8
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
7.9
49.5
132
259
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
11.7
44.2
87
99
WX408
NOMESCO Finland
General anesthesy, balanced
4.7
35.8
168
603
C64
ICD-10 Finland
Malignant neoplasm of kidney, except renal pelvis
52.0
31.3
37
8
KA1AE
NOMESCO Finland
Kidney ultrasound examination
14.2
30.6
53
44
JN4AD
NOMESCO Finland
Body CT examination
6.4
28.3
82
164
TPH07
NOMESCO Finland
Cathetrisation of artery
5.4
27.6
94
229
WX302
NOMESCO Finland
Thoracal epidural anesthesy
7.7
26.9
66
104
JN4CD
NOMESCO Finland
Very extensive body CT
9.4
26.6
57
72
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.6
25.6
213
1142
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
7.0
25.2
66
114
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
9.1
23.6
51
65
JN4BD
NOMESCO Finland
Extensive body CT
4.7
23.5
91
250
N02AX02
ATC
tramadol; systemic, rectal
3.3
22.4
197
1051
JN3AD
NOMESCO Finland
Abdominal CT examination
5.9
21.7
65
133
R4110
NOMESCO Finland
Physiotherapy
3.4
21.3
136
569
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
11.1
18.9
36
36
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
12.1
18.7
34
31
WX402
NOMESCO Finland
General anaesthesia
3.6
17.6
90
310
205
Kela drug reimbursment
Chronic hypertension
2.8
16.7
149
752
B01AB05
ATC
enoxaparin; parenteral
2.8
16.6
147
739
N02BE01
ATC
paracetamol; systemic, rectal
4.2
15.2
297
2372
JN1CD
NOMESCO Finland
Very extensive CT examination of upper part of abdomen
33.5
15.0
19
6
D30.0
ICD-10 Finland
Benign neoplasm: Kidney
26.5
14.9
20
8
A12AA04
ATC
calcium carbonate; oral
13.4
14.6
25
20
N18.8
ICD-10 Finland
Other chronic renal failure
7.1
14.6
36
56
197
Kela drug reimbursment
Sunitinib
38.0
14.6
18
5
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
6.6
14.3
37
62
U14
ICPC
Kidney symptom/complaint
11.2
14.0
26
25
Z49.1
ICD-10 Finland
Extracorporeal dialysis
21.2
14.0
20
10
N28.1
ICD-10 Finland
Cyst of kidney
14.5
13.9
23
17
A11CC03
ATC
alfacalcidol; systemic
8.6
13.9
30
38
V03AE01
ATC
polystyrene sulfonate; oral
22.3
13.5
19
9
L01XE04
ATC
[U] sunitinib; oral
42.0
13.3
16
*
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
17.7
13.2
20
12
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
9.1
13.1
27
32
TK800
NOMESCO Finland
Hemodialysis
7.9
12.8
29
40
196
Kela drug reimbursment
Paricalcitol and cinacalcet
135.1
12.5
13
*
Z94.0
ICD-10 Finland
Kidney transplant status
15.1
12.4
20
14
U75
ICPC
Malignant neoplasm of kidney
22.3
12.1
17
8
KA3LT
NOMESCO Finland
Njurlesion coagulation
67.5
11.7
13
*
KAC00
NOMESCO Finland
Nephrectomy
67.5
11.7
13
*
Z49.0
ICD-10 Finland
Preparatory care for dialysis
23.9
11.7
16
7
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.9
11.6
81
335
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
4.1
11.6
46
125
B03XA02
ATC
darbepoetin alfa; parenteral
9.4
11.0
22
25
137
Kela drug reimbursment
Uraemia requiring dialysis
18.6
10.8
16
9
H05BX01
ATC
cinacalcet; oral
22.4
10.8
15
7
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
22.4
10.8
15
7
C08CA01
ATC
amlodipine; oral
2.2
10.8
162
1004
127
Kela drug reimbursment
Transplant complication
10.6
10.7
20
20
JN3BD
NOMESCO Finland
Extensive abdominal CT
3.1
10.5
62
229
N18.0
ICD-10 Finland
End-stage renal disease
16.8
10.5
16
10
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
4.3
10.2
38
97
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
2.6
10.0
79
353
JN3CG
NOMESCO Finland
Extensive MRI examination of abdomen with high intensity magnet
56.7
9.7
11
*
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
18.2
9.5
14
8
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.5
9.5
45
143
KAC01
NOMESCO Finland
Percutaneous endoscopic nephrectomy
102.9
9.5
10
*
1502
Kela drug reimbursment
Cabozantinib
+∞
9.4
9
*
I10
ICD-10 Finland
Essential (primary) hypertension
2.1
9.1
226
1690
JN3KE
NOMESCO Finland
Abdominal ultrasound with added contrast
19.3
9.0
13
7
M04AA01
ATC
allopurinol; systemic
2.5
9.0
75
344
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
13.0
9.0
15
12
ZXA05
NOMESCO Finland
Left side
2.2
8.5
100
543
KA3CT
NOMESCO Finland
Biopsy of kidney under CT guidance
92.4
8.5
9
*
WX110
NOMESCO Finland
Local anesthesy
2.0
8.4
219
1642
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
11.2
8.4
15
14
KB1CG
NOMESCO Finland
Extensive MRI examination of urinary tract with high intensity magnet
+∞
8.4
8
*
S18
ICPC
Laceration/cut
2.0
8.1
157
1041
320
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
34.3
8.1
10
*
UKC02
NOMESCO Finland
Cystoscopy
2.3
8.0
86
442
J01MA02
ATC
ciprofloxacin; systemic
2.0
8.0
147
954
L04AA06
ATC
mycophenolic acid; systemic
8.1
8.0
17
22
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
3.5
7.8
36
112
B05DA
ATC
Isotonic solutions
15.5
7.8
12
8
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
15.5
7.8
12
8
158
Kela drug reimbursment
Everolimus
46.1
7.7
9
*
JN1BD
NOMESCO Finland
Extensive CT examination of upper part of abdomen
18.9
7.7
11
6
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
12.3
7.6
13
11
D41.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Renal pelvis
25.7
7.6
10
*
130
Kela drug reimbursment
Malignant tumour
2.8
7.4
49
194
TPH04
NOMESCO Finland
Cathetrisation of vein
2.2
7.4
84
445
KH1BD
NOMESCO Finland
Extensive urinary tract CT examination
11.2
7.4
13
12
KH1CD
NOMESCO Finland
Very extensive urinary tract ultrasound examination
9.7
7.4
14
15
3012
Kela drug reimbursment
Cabozantinib
+∞
7.3
7
*
C08CA02
ATC
felodipine; oral
2.7
7.3
52
216
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.3
7.2
71
349
V03AE02
ATC
sevelamer; oral
20.6
7.2
10
5
C09AA02
ATC
enalapril; systemic
2.1
6.9
88
485
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
14.2
6.9
11
8
PG5RT
NOMESCO Finland
PTA of arterio-venous shunt for dialysis
40.9
6.8
8
*
C02AC05
ATC
moxonidine; oral
3.3
6.7
32
103
N02AJ06
ATC
codeine and paracetamol; systemic
1.9
6.7
123
784
R31
ICD-10 Finland
Unspecified haematuria
2.4
6.6
56
255
L04AA01
ATC
[U] ciclosporin; systemic
9.0
6.6
13
15
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
10.3
6.6
12
12
ZXA00
NOMESCO Finland
Right side
2.0
6.6
102
610
C03CA01
ATC
furosemide; systemic
2.0
6.5
106
643
Z49.2
ICD-10 Finland
Other dialysis
14.7
6.4
10
7
KB1DG
NOMESCO Finland
Very extensive MRI of urinary tract
+∞
6.3
6
*
L01XE26
ATC
[U] cabozantinib; oral
+∞
6.3
6
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.9
6.2
102
621
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.9
6.1
106
662
C08CA13
ATC
lercanidipine; oral
2.3
6.0
57
273
GD1AD
NOMESCO Finland
Thorax CT examination
3.5
6.0
26
78

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3000991) Gas panel - Venous blood
106
287
4.89
37.52
10.8
10.5
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
65
115
6.73
36.71
2.3
3.7
g/l
0.2
0.2
0.27
41
55
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
235
1172
4.15
34.91
6.2
3.3
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
106
303
4.61
34.80
12.9
7.9
mmol/l
12.4
10.4
2.12
100
286
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
88
219
5.05
34.26
9.2
4.1
ng/l
162.2
89.2
4.30
81
196
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
85
210
5.04
33.32
8.6
11.3
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
204
970
3.70
31.52
2.9
2.5
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
189
859
3.65
31.28
5.8
3.1
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
251
1393
3.94
29.95
5.0
4.3
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
192
901
3.55
29.82
6.0
3.2
e6/l
0.2
0.5
1.99
170
688
(3024561) Albumin [Mass/volume] in Serum or Plasma
244
1339
3.81
29.40
9.1
5.5
g/l
34.8
34.9
0.13
226
1254
(3002582) Erythrocytes [#/volume] in Urine
203
997
3.52
29.10
6.3
3.3
e6/l
23.7
130.1
0.99
182
780
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
75
186
4.87
29.02
9.5
12.7
mmol/l
23.0
24.6
7.34
75
175
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
166
724
3.49
28.75
2.8
2.6
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
123
447
3.72
28.25
15.1
6.0
mmol/l
1.1
1.0
2.52
117
412
(3000850) Epithelial cells [#/volume] in Urine
159
689
3.43
27.59
4.5
2.6
e6/l
2.8
3.6
0.83
148
610
(3026782) Osmolality of Urine
152
648
3.41
26.96
4.8
2.9
mosm/kgh2o
551.0
574.2
0.79
140
553
(3014576) Chloride [Moles/volume] in Serum or Plasma
121
455
3.56
26.10
10.2
8.0
mmol/l
104.5
104.0
0.73
121
441
(4035726)
92
289
3.98
25.92
1.3
1.4
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
131
525
3.41
25.44
4.9
3.1
e6/l
0.8
1.5
0.97
79
302
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
242
1402
3.43
25.01
15.3
6.9
mmol/l
1.2
1.2
0.05
227
1276
(3018095) Leukocytes [#/volume] in Urine
208
1107
3.21
24.77
7.3
3.9
e6/l
45.7
67.0
0.54
182
824
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
132
549
3.27
23.88
4.6
2.9
e6/l
0.4
1.0
2.79
80
323
(3037467) Urinalysis macro (dipstick) panel - Urine
289
1990
3.79
20.16
6.3
4.3
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
311
2277
4.71
19.13
12.6
8.8
u/l
80.8
80.0
0.13
300
2137
(3003396) Base excess in Arterial blood by calculation
105
428
3.09
19.08
10.2
8.6
mmol/l
-1.1
1.3
9.37
93
331
(40768804) Tissue Pathology biopsy report
197
1127
2.74
18.73
2.8
2.2
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
238
1520
2.82
17.85
17.1
7.8
mmol/l
1.2
1.2
0.08
205
1296
(3032080) INR in Blood by Coagulation assay
219
1353
2.69
17.35
8.8
9.8
inr
1.2
1.3
0.61
49
359
(3018418) pH of Serum or Plasma
164
919
2.50
15.38
11.5
4.6
ph
7.4
7.4
0.65
28
168
(3026493) Urate [Moles/volume] in Serum or Plasma
155
875
2.40
13.96
4.3
2.9
umol/l
389.2
6107.6
3.25
138
751
(3013826) Glucose [Moles/volume] in Serum or Plasma
259
1842
2.63
13.75
8.1
5.5
mmol/l
6.7
6.8
0.41
252
1746
(42870588) Differential panel, method unspecified - Blood
166
978
2.34
13.42
5.4
6.0
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
147
829
2.35
13.07
3.0
3.4
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
163
970
2.29
12.68
5.6
4.6
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
238
1675
2.36
12.16
10.0
10.0
e9/l
4.7
4.2
1.50
203
1478
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
95
453
2.51
12.15
6.5
2.4
%
20.9
23.0
0.86
81
390
(3015377) Calcium [Moles/volume] in Serum or Plasma
165
1003
2.24
12.01
5.0
4.0
mmol/l
2.4
2.3
0.92
143
868
(3004789) Transferrin [Mass/volume] in Serum or Plasma
97
473
2.46
11.78
6.3
2.4
g/l
2.2
2.3
0.61
89
433
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
109
572
2.32
11.15
3.7
3.7
mmol/l
2.5
2.5
0.62
90
499
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
38
120
3.43
10.21
1.9
2.4
u/ml
0.3
0.4
0.21
12
59
(40758558) Short blood count panel - Blood
126
724
2.17
10.19
5.8
7.4
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
71
319
2.54
10.14
8.0
4.0
mmol/l
1.1
2.1
2.00
63
248
(3021447) Carbon dioxide [Partial pressure] in Venous blood
71
320
2.53
10.07
8.0
4.1
kpa
5.8
5.8
0.11
71
308
(3022948) Iron [Moles/volume] in Serum or Plasma
97
517
2.22
9.35
6.4
2.4
umol/l
10.9
12.8
2.01
90
477
(3012544) pH of Venous blood
71
332
2.43
9.27
8.1
4.1
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
159
1034
2.00
8.94
4.8
3.3
mmol/l
7.1
8.0
2.76
133
842
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
219
1600
2.01
8.72
8.4
7.6
umol/l
10.5
12.5
2.11
208
1525
(3022096) Basophils/100 leukocytes in Blood
188
1312
1.95
8.46
5.9
6.1
%
0.7
0.6
0.93
176
1235
(3012516) Albumin [Mass/volume] in Urine
153
1006
1.94
8.12
5.3
3.3
mg/l
411.5
288.2
0.16
121
673
(3006504) Eosinophils/100 leukocytes in Blood
189
1339
1.91
7.95
5.9
6.2
%
2.9
2.9
0.08
176
1259
(3019069) Monocytes/100 leukocytes in Blood
190
1349
1.91
7.93
6.2
6.4
%
9.0
9.1
0.15
176
1272
(3002030) Lymphocytes/100 leukocytes in Blood
191
1370
1.88
7.61
6.1
6.3
%
23.2
26.3
3.63
176
1284
(3052851) Hemolysis interference index of Serum or Plasma
29
93
3.31
7.60
3.6
3.7
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
189
1354
1.88
7.53
5.9
6.0
%
61.7
57.8
4.33
176
1280
(40768446) Kidney Pathology biopsy report
12
9
13.76
7.44
1.3
1.3
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
157
1065
1.87
7.39
5.8
4.1
mg/mmol
24.2
9.0
2.84
120
684
(3004588) Protein electrophoresis panel - Serum or Plasma
52
234
2.44
7.31
2.9
3.0
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
200
1469
1.86
7.26
6.4
6.2
e9/l
0.2
0.2
1.03
175
1300
(3013707) Erythrocyte sedimentation rate by Westergren method
264
2125
2.03
7.21
5.5
4.3
mm/h
17.4
12.9
2.54
241
1949
(3006315) Basophils [#/volume] in Blood
195
1432
1.83
6.97
6.1
6.0
e9/l
0.0
0.0
0.99
163
1248
(3001604) Monocytes [#/volume] in Blood
194
1429
1.82
6.81
6.1
6.0
e9/l
0.7
0.6
1.41
161
1235
(46235355) HIV 1 and 2 tests - Meaningful Use set
64
331
2.15
6.47
3.1
1.6
—
—
—
0
0
(3002256) Pathology report gross observation
70
375
2.09
6.46
1.3
1.3
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
195
1454
1.78
6.42
6.2
6.1
e9/l
1.7
1.9
0.76
167
1289
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
38
159
2.56
6.21
1.9
1.9
g/l
2.0
1.5
1.47
31
137
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
319
2821
2.74
6.10
28.0
17.1
mg/l
37.9
27.2
4.50
291
2310
(3012095) Magnesium [Moles/volume] in Serum or Plasma
90
543
1.89
5.89
4.4
3.6
mmol/l
0.8
0.8
0.22
85
512
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
46
220
2.26
5.62
4.6
2.9
ml/min/173m2
41.4
60.6
3.91
29
97
(3042733) HLA Ab [Presence] in Serum
9
7
13.15
5.61
7.7
4.3
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
38
169
2.40
5.47
2.9
2.8
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
152
1091
1.70
5.44
3.3
2.2
nmol/l
80.5
77.1
0.69
135
956
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
8
5
16.32
5.43
8.8
4.6
mmol/l
5.6
7.2
—
8
5
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
32
132
2.57
5.39
2.3
3.1
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
15
39
3.98
5.32
2.2
2.7
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
52
270
2.09
5.18
5.4
3.0
kpa
5.1
4.4
1.63
52
258
(3001122) Ferritin [Mass/volume] in Serum or Plasma
156
1139
1.67
5.16
5.4
2.6
ug/l
211.4
174.0
0.57
149
1035
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
98
634
1.76
5.03
4.3
4.0
ng/l
242.1
366.7
0.30
88
544
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
18
56
3.34
4.96
7.6
2.8
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
134
949
1.67
4.93
3.1
2.7
u/l
61.2
56.6
0.84
121
886
(3024928) Oxygen saturation in Venous blood
22
78
2.94
4.91
4.3
3.0
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
15
42
3.69
4.82
1.3
1.2
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
182
1404
1.63
4.71
4.6
3.7
estimate
0.0
0.0
0.00
39
266
(3023520) Reticulocytes [#/volume] in Blood
53
290
1.98
4.57
2.4
2.8
e9/l
64.2
71.1
0.85
38
226
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
86
550
1.75
4.54
2.2
1.9
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
16
49
3.38
4.52
2.9
3.0
—
829.5
—
0
6
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
12
30
4.11
4.47
1.0
1.1
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
67
401
1.83
4.41
2.4
2.6
%
1.8
1.8
0.01
62
361
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
40
201
2.12
4.33
2.1
1.6
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
50
275
1.96
4.25
3.4
1.6
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
21
79
2.77
4.24
1.7
1.2
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
181
1423
1.57
4.13
4.8
3.7
estimate
0.0
0.0
0.00
39
253
(3003694) ABO and Rh group [Type] in Blood
107
746
1.63
4.05
1.4
1.3
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
111
783
1.62
4.00
2.5
2.0
mg/l
3.3
3.1
0.25
98
680
(3011397) Hemoglobin [Presence] in Urine by Test strip
96
653
1.65
4.00
4.3
3.6
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
178
1403
1.56
3.96
6.2
5.0
estimate
0.0
0.0
0.00
39
266
(3021879) Hepatitis B virus core Ab [Presence] in Serum
36
180
2.12
3.96
1.5
1.4
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
49
275
1.91
3.93
3.7
1.5
—
—
—
0
0
(1616796) Gas panel - Central venous blood
19
71
2.77
3.89
5.1
3.2
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
284
2507
1.75
3.86
33.5
18.0
%
38.3
40.1
2.61
204
1671
(3019550) Sodium [Moles/volume] in Serum or Plasma
325
3005
2.41
3.75
38.0
20.0
mmol/l
139.1
139.6
3.12
316
2931
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
17
61
2.88
3.74
1.4
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
17
61
2.88
3.74
1.4
1.4
—
—
—
0
0
(3019225) pH of Specimen
50
287
1.87
3.74
8.6
4.5
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
164
1288
1.52
3.60
2.2
2.0
pmol/l
97.3
92.6
0.41
84
679
(3023103) Potassium [Moles/volume] in Serum or Plasma
325
3015
2.34
3.54
38.6
20.2
mmol/l
4.1
4.0
5.72
316
2942
(3017817) Protein [Mass] in Urine collected for unspecified duration
12
36
3.42
3.51
3.7
2.7
—
—
—
0
0
(3022145) Colonoscopy Study observation
55
333
1.78
3.47
1.3
1.3
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
38
205
1.96
3.42
5.2
3.7
mmol/l
0.5
1.9
1.68
30
163
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
54
327
1.77
3.40
4.7
3.4
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
61
384
1.71
3.36
2.1
1.9
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
61
386
1.70
3.30
1.2
1.3
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
61
388
1.70
3.24
2.2
1.9
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
11
33
3.41
3.22
5.0
2.4
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
7
11
6.47
3.20
3.4
1.8
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
20
86
2.41
3.14
4.0
5.0
—
—
—
0
0
(3044889) 12 lead EKG panel
245
2128
1.52
3.10
4.9
4.3
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
13
45
2.96
3.06
1.2
1.4
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
159
1273
1.46
3.01
13.4
10.5
e9/l
0.0
0.0
0.55
126
1049
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
27
135
2.08
3.00
6.1
4.3
mmol/l
24.3
25.2
0.67
21
127
(3051387) C reactive protein [Mass/volume] in Capillary blood
0
79
0.00
2.98
0.0
4.3
—
26.6
—
0
49
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
13
46
2.90
2.95
1.4
1.1
—
—
—
0
0
(3009343) pH of Capillary blood
38
216
1.85
2.95
5.3
3.7
ph
7.4
7.4
—
5
23
(3047189) Immunofixation for 24 hour Urine
8
17
4.79
2.93
1.4
1.7
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
17
70
2.50
2.92
1.1
1.3
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
21
96
2.26
2.90
1.2
1.3
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
37
210
1.85
2.88
1.6
1.7
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
297
2713
1.68
2.84
29.1
15.8
ml/min/173m2
62.0
77.3
19.27
275
2285
(3022313) Gas panel - Capillary blood
30
161
1.95
2.76
5.4
3.8
—
—
—
0
0
(3024471) HLA-A [Type]
6
10
6.08
2.71
1.0
1.0
—
—
—
0
0
(3024932) HLA-DR beta [Type]
6
10
6.08
2.71
1.0
1.2
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
8
19
4.28
2.69
1.1
1.1
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
315
2934
1.85
2.68
29.0
15.9
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
16
67
2.46
2.67
1.1
1.3
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
31
171
1.89
2.64
4.9
2.9
%
1.2
1.2
0.10
31
171
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
35
202
1.82
2.60
1.3
1.4
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
12
44
2.79
2.57
1.2
1.3
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
72
505
1.54
2.56
2.3
2.1
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
70
965
0.66
2.56
2.8
3.1
—
—
—
0
0
(40768441) Liver Pathology biopsy report
8
21
3.87
2.47
1.0
1.2
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
6
12
5.07
2.41
1.0
1.5
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
6
12
5.07
2.41
1.0
1.5
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
9
27
3.39
2.41
1.0
1.3
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
14
58
2.47
2.40
3.2
1.4
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
8
22
3.70
2.38
1.1
1.1
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
207
1789
1.39
2.34
5.1
5.2
ug/l
2.2
2.7
1.03
195
1601
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
14
59
2.43
2.32
3.2
1.4
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
9
28
3.27
2.32
1.3
1.2
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
130
1041
1.40
2.31
2.9
3.2
ng/l
2707.7
1474.5
0.87
115
904
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
130
1042
1.40
2.30
3.2
3.1
ug/l
0.8
0.8
0.15
105
713
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
14
60
2.39
2.25
1.6
1.2
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
101
778
1.42
2.23
1.9
1.5
nmol/l
19.3
20.4
0.29
95
656
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
53
359
1.56
2.20
3.5
5.0
ug/l
3.2
28.4
1.21
44
305
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
53
360
1.56
2.17
2.4
3.2
umol/l
7.7
10.8
0.58
46
321
(3048689) Calprotectin [Mass/mass] in Stool
41
266
1.61
2.04
2.1
2.4
ug/g
161.9
141.1
0.18
34
212
(40761536) Microorganisms panel - Urine sediment
38
242
1.64
2.03
7.2
3.8
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
19
98
1.99
1.99
2.4
1.6
—
—
—
0
0
(40761535) Cells panel - Urine sediment
39
254
1.60
1.92
4.9
3.5
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
12
52
2.35
1.90
1.5
1.6
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
210
1853
1.34
1.89
3.5
3.3
u/l
48.3
55.9
1.00
193
1722
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
83
637
1.40
1.85
1.5
1.7
mg/l
1.2
1.4
0.36
64
506
(3019832) Treponema pallidum Ab [Presence] in Serum
19
101
1.93
1.84
2.5
1.6
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
21
116
1.86
1.83
1.6
1.7
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
319
3034
1.68
1.80
15.6
11.7
u/l
24.9
27.2
2.28
305
2923
(3012501) Base excess in Blood by calculation
15
74
2.07
1.78
6.3
3.9
mmol/l
1.2
2.4
—
9
50
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
6
18
3.37
1.75
1.0
1.3
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
8
30
2.71
1.73
1.0
1.4
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
14
68
2.10
1.72
2.3
2.8
%
17.1
15.7
—
7
33
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
15
75
2.05
1.72
1.2
1.5
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
8
31
2.62
1.67
1.1
1.4
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
22
129
1.75
1.61
2.4
1.9
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
325
3118
1.73
1.60
44.2
24.5
e9/l
251.1
236.2
3.32
319
3040
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
6
20
3.03
1.58
1.5
1.2
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
325
3119
1.72
1.58
44.3
24.5
e9/l
7.4
6.8
5.03
318
3030
(3026361) Erythrocytes [#/volume] in Blood
325
3119
1.72
1.58
44.2
24.4
e12/l
4.4
4.5
5.33
318
3029
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
12
57
2.15
1.57
1.0
1.6
—
—
—
0
0
(4281824)
6
21
2.89
1.51
1.3
1.2
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
12
58
2.11
1.51
1.5
1.5
—
—
—
0
0
(4010399)
32
212
1.56
1.50
1.3
1.4
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
9
37
2.47
1.49
1.1
2.2
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
11
52
2.15
1.46
1.2
1.8
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
7
28
2.53
1.46
1.1
1.4
nmol/l
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
17
95
1.83
1.46
1.5
1.5
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
218
1973
1.29
1.44
4.2
3.4
pmol/l
14.9
15.0
0.13
192
1737
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
9
39
2.34
1.44
1.1
2.1
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
9
39
2.34
1.44
3.2
3.7
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
10
47
2.16
1.35
1.1
1.5
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
15
83
1.84
1.33
1.5
1.6
ug/g
324.0
255.7
—
8
48
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
268
2503
1.32
1.32
4.9
4.2
mu/l
2.2
2.0
0.42
242
2233
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
19
114
1.71
1.31
2.3
1.7
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
15
84
1.82
1.29
1.3
1.8
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
5
18
2.80
1.29
1.0
1.1
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
18
107
1.72
1.28
3.8
2.4
ug/min
215.5
79.9
0.50
13
58
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
21
131
1.64
1.26
1.7
1.8
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
23
147
1.60
1.26
1.1
1.2
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
15
85
1.80
1.25
1.5
1.6
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
163
1442
1.25
1.24
4.4
4.5
%
24.1
20.9
1.74
90
705
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
24
156
1.58
1.24
2.5
2.1
ug/l
0.4
3.3
0.91
18
136
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
11
56
2.00
1.23
1.1
2.0
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
8
37
2.19
1.22
1.3
1.9
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
8
37
2.19
1.22
1.3
1.9
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
8
37
2.19
1.22
1.3
1.9
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
5
19
2.65
1.22
1.4
2.2
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
5
19
2.65
1.22
1.4
2.2
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
5
19
2.65
1.22
1.4
2.2
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
5
19
2.65
1.22
1.4
2.2
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
15
86
1.78
1.21
1.4
1.8
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
6
26
2.33
1.19
1.0
1.1
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
14
80
1.78
1.14
1.7
1.2
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
21
136
1.58
1.11
2.6
3.2
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
17
105
1.65
1.08
2.2
1.8
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
15
90
1.70
1.06
1.3
4.0
umol/l
29.2
36.1
—
9
74
(3028626) Oxygen [Partial pressure] in Capillary blood
13
75
1.76
1.04
2.9
2.6
kpa
7.8
7.9
0.03
13
66
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
63
507
1.30
1.04
1.3
1.2
u/ml
1.7
1.2
0.19
13
140
(3017732) Neutrophils [#/volume] in Blood
26
180
1.48
1.04
3.5
2.8
e9/l
5.9
4.3
0.63
17
129
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
11
60
1.86
1.04
1.3
1.7
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
96
815
1.25
1.03
1.8
1.7
mmol/l
1.6
1.3
2.11
86
673
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
16
99
1.65
1.02
1.1
1.0
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
16
99
1.65
1.02
1.6
2.2
g/l
4.5
3.8
0.85
16
92
(3000492) Spirometry study
37
276
1.38
1.01
1.5
1.5
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
9
49
1.86
0.99
2.2
3.0
e9/l
4.8
4.4
—
9
49
(3022217) INR in Platelet poor plasma by Coagulation assay
58
465
1.30
0.99
41.4
25.3
inr
1.2
1.3
—
8
61
(3019060) Gas panel - Arterial blood
34
251
1.39
0.98
10.3
4.5
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
9
51
1.78
0.95
2.3
3.7
%
61.9
59.5
—
9
51
(3011648) Oxygen content in Venous blood
6
27
2.24
0.94
3.3
1.9
%
10.7
10.6
—
6
27
(3002523) Influenza virus A Ag [Presence] in Specimen
6
27
2.24
0.94
1.0
1.1
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
12
70
1.74
0.93
1.2
1.7
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
6
28
2.16
0.92
3.7
3.1
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
7
126
0.55
0.90
2.1
1.4
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
12
71
1.72
0.90
1.1
1.5
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
72
601
1.25
0.90
1.9
1.7
nmol/l
1510.7
1190.4
0.64
52
458
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
6
29
2.09
0.89
1.0
1.2
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
6
29
2.09
0.89
1.0
1.2
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
48
381
1.30
0.89
5.0
4.9
%
29.9
31.5
0.49
33
251
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
10
56
1.81
0.88
1.1
1.7
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
6
30
2.02
0.87
2.0
2.3
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
40
311
1.32
0.86
1.2
1.3
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
6
31
1.95
0.85
1.0
1.0
—
—
—
0
0
(3013512) EKG study
106
928
1.21
0.84
4.6
4.2
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
11
65
1.72
0.83
1.3
1.3
u/l
11.0
5.9
0.54
11
53
(3017569) Oxygen content in Arterial blood
0
24
0.00
0.79
0.0
4.7
—
—
—
0
0
(40768793) Breast Pathology biopsy report
6
33
1.83
0.79
1.0
1.3
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
0
26
0.00
0.78
0.0
4.3
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
0
27
0.00
0.77
0.0
2.2
—
722.8
—
0
12
(3021788) Differential panel - Synovial fluid
10
59
1.72
0.76
1.1
1.4
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
13
83
1.59
0.76
1.1
1.5
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
291
2803
1.24
0.75
5.3
5.0
mmol/l
6.2
6.1
0.10
255
2539
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
5
24
2.10
0.75
1.4
1.1
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
39
310
1.29
0.73
2.7
2.6
ug/l
5.9
8.8
0.91
34
282
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
7
39
1.81
0.73
3.3
2.8
—
34.4
—
0
9
(3014051) Protein [Presence] in Urine by Test strip
9
57
1.59
0.71
2.2
2.1
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
299
2893
1.25
0.70
5.7
5.4
mmol/l
2.4
2.6
2.39
267
2632
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
293
2829
1.24
0.70
5.1
4.8
mmol/l
4.3
4.4
1.44
260
2593
(3017181) Myelocytes/100 leukocytes in Blood
18
249
0.71
0.69
3.4
4.6
%
0.9
1.0
—
6
88
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
18
127
1.44
0.69
1.9
2.1
u/l
34.9
38.3
0.24
18
114
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
17
119
1.45
0.68
1.2
1.2
iu/ml
103.4
114.8
—
5
34
(1761482) Bacteria [#/volume] in Urine by Culture
5
91
0.54
0.68
7.0
4.8
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
160
1476
1.16
0.66
3.0
2.4
—
—
—
0
0
(44790049)
7
44
1.60
0.65
1.6
1.6
—
—
—
0
0
(44806118)
7
44
1.60
0.65
1.6
1.6
—
—
—
0
0
(44790048)
7
44
1.60
0.65
1.6
1.6
—
—
—
0
0
(44790047)
7
44
1.60
0.65
1.6
1.6
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
19
138
1.40
0.64
1.2
1.2
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
122
1106
1.16
0.63
4.8
3.9
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
284
2743
1.20
0.62
7.6
6.4
mmol/mol
40.7
40.9
0.10
255
2533
(3015235) Bicarbonate [Moles/volume] in Capillary blood
13
88
1.50
0.61
3.1
2.7
mmol/l
23.2
25.0
1.24
13
74
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
0
21
0.00
0.60
0.0
1.5
—
15.6
—
0
21
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
0
22
0.00
0.59
0.0
1.0
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
0
23
0.00
0.58
0.0
1.7
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
136
1251
1.14
0.57
4.2
4.0
ng/l
44.8
50.2
0.17
102
956
(3051611) Lipemic interference index of Serum or Plasma
6
36
1.68
0.57
3.8
3.3
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
10
65
1.55
0.56
2.9
2.7
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
6
37
1.63
0.56
3.8
2.8
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
6
37
1.63
0.56
2.2
1.4
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
6
37
1.63
0.56
1.0
1.6
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
44
370
1.22
0.54
13.0
8.6
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
6
39
1.55
0.53
1.0
1.6
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
6
39
1.55
0.53
1.0
1.6
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
6
39
1.55
0.53
1.0
1.6
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
55
634
0.84
0.53
5.7
4.2
kg/l
1.0
1.0
—
8
82
(3007853) Bacteria identified in Skin by Aerobe culture
45
381
1.21
0.52
2.1
1.8
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
6
40
1.51
0.52
1.0
1.6
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
6
40
1.51
0.52
1.0
1.6
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
87
781
1.15
0.51
4.4
3.4
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
12
84
1.44
0.50
1.5
1.3
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
21
163
1.31
0.49
1.2
1.2
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
7
46
1.53
0.48
1.0
1.7
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
56
488
1.18
0.48
1.4
1.4
g/l
2.2
2.8
1.69
34
294
(21494755) Public health laboratory ask at order entry panel
14
188
0.73
0.48
1.2
1.4
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
33
395
0.82
0.48
1.2
1.3
u/ml
34.5
10.1
—
9
139
(3001019) Free T4 and TSH panel - Serum or Plasma
5
81
0.61
0.46
1.0
1.7
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
21
165
1.29
0.46
1.9
2.5
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
8
56
1.44
0.43
1.5
2.9
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
5
32
1.57
0.42
1.0
1.2
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
0
15
0.00
0.41
0.0
1.8
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
1.5
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
11
79
1.41
0.41
1.2
2.4
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
8
59
1.36
0.41
1.0
1.2
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
8
61
1.32
0.40
1.0
1.2
—
3.4
—
0
7
(3000494) Fungus identified in Specimen by Culture
44
384
1.17
0.38
2.0
1.5
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
5
36
1.39
0.38
1.2
1.2
—
—
—
0
0
(4306422)
5
36
1.39
0.38
1.4
1.2
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
280
2731
1.13
0.38
4.5
4.3
mmol/l
1.5
1.3
3.33
238
2475
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
288
2814
1.14
0.38
5.1
4.8
mmol/l
1.3
1.4
2.72
257
2552
(3007566) Smooth muscle Ab [Titer] in Serum
9
70
1.29
0.37
1.1
1.1
—
54.0
—
0
5
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
11
81
1.37
0.36
1.6
1.5
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
22
183
1.22
0.32
2.6
1.7
g/l
4.0
1.8
0.48
22
168
(3004716) Salmonella sp identified in Stool by Organism specific culture
13
101
1.30
0.32
1.3
1.3
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
26
304
0.84
0.32
1.5
1.5
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
7
53
1.33
0.31
1.0
1.1
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
11
84
1.32
0.30
2.3
1.5
—
0.0
—
0
21
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
38
428
0.87
0.30
1.2
1.3
iu/ml
137.1
33.6
0.84
11
133
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
8
62
1.30
0.28
1.0
1.2
—
1.6
—
0
9
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
102
961
1.09
0.27
2.3
2.1
u/l
127.3
295.5
1.46
96
899
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
9
72
1.26
0.26
1.3
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
9
72
1.26
0.26
1.3
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
9
73
1.24
0.25
1.3
1.2
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
16
190
0.83
0.24
2.0
1.8
—
—
—
0
0
(4034850)
7
94
0.74
0.22
38.9
13.2
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
10
79
1.27
0.22
1.3
1.7
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
5
40
1.25
0.22
1.2
1.3
iu/l
27.3
21.5
—
5
34
(3020891) Body temperature
16
135
1.19
0.22
12.3
4.4
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.2
—
151.5
—
0
11
(44806420)
0
11
0.00
0.21
0.0
2.1
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
17.2
—
1435.5
—
0
10
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
14.2
—
789.9
—
0
10
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(4015189)
0
10
0.00
0.21
0.0
3.0
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
0
10
0.00
0.21
0.0
2.2
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
12
0.00
0.21
0.0
2.2
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
12
0.00
0.21
0.0
1.6
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
0
12
0.00
0.21
0.0
1.5
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
4.7
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
0
13
0.00
0.21
0.0
4.7
—
138.4
—
0
13
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
0
13
0.00
0.21
0.0
1.5
—
68.6
—
0
13
(3008757) Leukocyte morphology finding [Identifier] in Blood
6
48
1.25
0.20
4.5
4.6
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
14
0.00
0.20
0.0
1.5
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
6
50
1.20
0.20
3.8
2.5
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
6
50
1.20
0.20
3.8
2.5
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
6
51
1.18
0.19
3.8
1.8
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
6
52
1.16
0.19
3.8
2.5
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
6
52
1.16
0.19
3.8
2.5
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
56
596
0.93
0.17
5.7
5.2
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
5
66
0.75
0.17
1.2
1.8
—
—
—
0
0
(1002224) Polysomnography panel
14
120
1.17
0.16
1.0
1.1
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
13
150
0.86
0.15
1.9
1.4
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
10
84
1.20
0.14
2.3
2.0
mg/l
13.1
12.6
—
10
77
(3022621) pH of Urine by Test strip
21
191
1.11
0.12
3.9
2.9
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
11
126
0.87
0.11
1.4
1.8
nmol/l
44.1
43.2
0.04
11
119
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
5
46
1.09
0.09
1.0
1.2
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
5
46
1.09
0.09
1.0
1.1
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
14
126
1.12
0.09
1.2
1.2
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
15
136
1.11
0.08
1.6
1.3
—
—
—
0
0
(3008898) HLA-B27 [Presence]
6
73
0.82
0.07
1.0
1.1
—
—
—
0
0
(4094501)
7
81
0.86
0.07
1.1
1.1
—
—
—
0
0
(40768443) Skin Pathology biopsy report
15
138
1.09
0.06
1.1
1.3
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
11
101
1.09
0.04
1.5
1.7
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
34
351
0.97
0.03
1.9
2.3
nmol/l
12.0
13.0
0.37
29
309
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
18
173
1.04
0.01
2.4
2.5
—
11.9
—
0
9
(3029937) Albumin [Presence] in Urine by Test strip
79
783
1.01
0.01
6.1
4.0
estimate
0.1
0.0
0.49
36
254
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
16
154
1.04
0.00
1.2
1.4
—
42.2
—
0
11
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
66
666
0.99
0.00
1.9
1.8
pmol/l
468.5
7407834.4
0.50
53
540
(3043409) Potassium [Moles/volume] in Arterial blood
12
115
1.05
0.00
10.8
3.3
mmol/l
4.0
4.0
0.04
12
103
(3016650) Hepatitis A virus Ab [Presence] in Serum
5
49
1.02
0.00
1.0
1.1
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
16.7
—
0
5
(3014891) Appearance of Pleural fluid
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
0
6
0.00
0.00
0.0
1.2
—
101.5
—
0
6
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
26.3
—
0
5
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3035509) Tobramycin [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.8
—
0.9
—
0
6
(3042631) Mycobacterium sp identified in Specimen
5
51
0.98
0.00
1.4
2.9
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
10.2
—
0.7
—
0
9
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
9
92
0.98
0.00
1.2
1.1
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
0
7
0.00
0.00
0.0
6.7
—
—
—
0
0
(3034426) Prothrombin time (PT)
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
5
0.00
0.00
0.0
4.2
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
6
63
0.95
0.00
1.0
1.3
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
15
150
1.00
0.00
3.7
3.8
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
6
0.00
0.00
0.0
7.7
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(4133840)
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
0
6
0.00
0.00
0.0
1.2
—
1.3
—
0
6
(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(4198724)
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3016244) Insulin [Units/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
2.2
—
15.1
—
0
9
(3034988) Calcium [Moles/volume] in Capillary blood
0
7
0.00
0.00
0.0
1.1
—
1.2
—
0
7

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: C3_KIDNEY_PAPILLARYADENO – Adenocarcinoma and Papillary adenocarcinoma of kidney

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).